Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The nature and evolving treatment of myelodysplastic syndromes.

× No keyword cloud information.

22 in total

Review 1. The differentiation of myeloid leukaemia cells: new possibilities for therapy.

Authors: L Sachs
Journal: Br J Haematol Date: 1978-12 Impact factor: 6.998

Review 2. Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation.

Authors: M Hozumi
Journal: Adv Cancer Res Date: 1983 Impact factor: 6.242

3. Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome.

Authors: A W Nienhuis; H F Bunn; P H Turner; T V Gopal; W G Nash; S J O'Brien; C J Sherr
Journal: Cell Date: 1985-09 Impact factor: 41.582

4. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.

Authors: R S Negrin; D H Haeuber; A Nagler; L C Olds; T Donlon; L M Souza; P L Greenberg
Journal: Ann Intern Med Date: 1989-06-15 Impact factor: 25.391

Review 5. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.

Authors: D Metcalf
Journal: Blood Date: 1986-02 Impact factor: 22.113

6. Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein.

Authors: J Lotem; L Sachs
Journal: Proc Natl Acad Sci U S A Date: 1982-07 Impact factor: 11.205

7. Regulator-induced suppression of myelomonocytic leukemic cells: clonal analysis of early cellular events.

Authors: D Metcalf
Journal: Int J Cancer Date: 1982-08-15 Impact factor: 7.396

8. Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.

Authors: E J Gold; R H Mertelsmann; L M Itri; T Gee; Z Arlin; S Kempin; B Clarkson; M A Moore
Journal: Cancer Treat Rep Date: 1983-11

9. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.

Authors: R H Jacobs; M A Cornbleet; J W Vardiman; R A Larson; M M Le Beau; J D Rowley
Journal: Blood Date: 1986-06 Impact factor: 22.113

10. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

Authors: M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; H M Golomb; J D Rowley
Journal: J Clin Oncol Date: 1986-03 Impact factor: 44.544